France Non-Small Cell Lung Cancer Diagnostics Market (2025-2031) | Trends, Competitive Landscape, Outlook, Share, Analysis, Companies, Industry, Size & Revenue, Forecast, Value, Segmentation, Growth

Market Forecast By Cancer Type (Lung Adenocarcinoma (LUAD), Lung Squamous Cell carcinoma (LUSC), Large Cell Carcinoma, Others), By Product (Reagents & Kits, Instruments And Services & Softwares), By Test (Imaging Test, Molecular Test, Biopsy, Sputum Cytology, Thoracentesis, Immunohistochemistry, Others), By End-User (Hospital, Clinical Laboratories, Academics, Others) And Competitive Landscape
Product Code: ETC7224589 Publication Date: Sep 2024 Updated Date: Aug 2025 Product Type: Market Research Report
Publisher: 6Wresearch No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

Key Highlights of the Report:

  • France Non-Small Cell Lung Cancer Diagnostics Market Outlook
  • Market Size of France Non-Small Cell Lung Cancer Diagnostics Market, 2024
  • Forecast of France Non-Small Cell Lung Cancer Diagnostics Market, 2031
  • Historical Data and Forecast of France Non-Small Cell Lung Cancer Diagnostics Revenues & Volume for the Period 2021- 2031
  • France Non-Small Cell Lung Cancer Diagnostics Market Trend Evolution
  • France Non-Small Cell Lung Cancer Diagnostics Market Drivers and Challenges
  • France Non-Small Cell Lung Cancer Diagnostics Price Trends
  • France Non-Small Cell Lung Cancer Diagnostics Porter's Five Forces
  • France Non-Small Cell Lung Cancer Diagnostics Industry Life Cycle
  • Historical Data and Forecast of France Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume By Cancer Type for the Period 2021- 2031
  • Historical Data and Forecast of France Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume By Lung Adenocarcinoma (LUAD) for the Period 2021- 2031
  • Historical Data and Forecast of France Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume By Lung Squamous Cell carcinoma (LUSC) for the Period 2021- 2031
  • Historical Data and Forecast of France Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume By Large Cell Carcinoma for the Period 2021- 2031
  • Historical Data and Forecast of France Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of France Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume By Product for the Period 2021- 2031
  • Historical Data and Forecast of France Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume By Reagents & Kits for the Period 2021- 2031
  • Historical Data and Forecast of France Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume By Instruments And Services & Softwares for the Period 2021- 2031
  • Historical Data and Forecast of France Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume By Test for the Period 2021- 2031
  • Historical Data and Forecast of France Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume By Imaging Test for the Period 2021- 2031
  • Historical Data and Forecast of France Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume By Molecular Test for the Period 2021- 2031
  • Historical Data and Forecast of France Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume By Biopsy for the Period 2021- 2031
  • Historical Data and Forecast of France Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume By Sputum Cytology for the Period 2021- 2031
  • Historical Data and Forecast of France Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume By Thoracentesis for the Period 2021- 2031
  • Historical Data and Forecast of France Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume By Immunohistochemistry for the Period 2021- 2031
  • Historical Data and Forecast of France Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of France Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume By End-User for the Period 2021- 2031
  • Historical Data and Forecast of France Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume By Hospital for the Period 2021- 2031
  • Historical Data and Forecast of France Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume By Clinical Laboratories for the Period 2021- 2031
  • Historical Data and Forecast of France Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume By Academics for the Period 2021- 2031
  • Historical Data and Forecast of France Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume By Others for the Period 2021- 2031
  • France Non-Small Cell Lung Cancer Diagnostics Import Export Trade Statistics
  • Market Opportunity Assessment By Cancer Type
  • Market Opportunity Assessment By Product
  • Market Opportunity Assessment By Test
  • Market Opportunity Assessment By End-User
  • France Non-Small Cell Lung Cancer Diagnostics Top Companies Market Share
  • France Non-Small Cell Lung Cancer Diagnostics Competitive Benchmarking By Technical and Operational Parameters
  • France Non-Small Cell Lung Cancer Diagnostics Company Profiles
  • France Non-Small Cell Lung Cancer Diagnostics Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6Wresearch actively monitors the France Non-Small Cell Lung Cancer Diagnostics Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the France Non-Small Cell Lung Cancer Diagnostics Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 France Non-Small Cell Lung Cancer Diagnostics Market Overview

3.1 France Country Macro Economic Indicators

3.2 France Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, 2021 & 2031F

3.3 France Non-Small Cell Lung Cancer Diagnostics Market - Industry Life Cycle

3.4 France Non-Small Cell Lung Cancer Diagnostics Market - Porter's Five Forces

3.5 France Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F

3.6 France Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume Share, By Product, 2021 & 2031F

3.7 France Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume Share, By Test, 2021 & 2031F

3.8 France Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume Share, By End-User, 2021 & 2031F

4 France Non-Small Cell Lung Cancer Diagnostics Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing incidence and prevalence of non-small cell lung cancer in France

4.2.2 Technological advancements in diagnostic tools and techniques

4.2.3 Growing awareness among healthcare professionals and patients about the importance of early detection

4.3 Market Restraints

4.3.1 Stringent regulatory requirements for approval of diagnostic tests

4.3.2 High cost associated with advanced diagnostic technologies

4.3.3 Limited reimbursement policies for certain diagnostic procedures

5 France Non-Small Cell Lung Cancer Diagnostics Market Trends

6 France Non-Small Cell Lung Cancer Diagnostics Market, By Types

6.1 France Non-Small Cell Lung Cancer Diagnostics Market, By Cancer Type

6.1.1 Overview and Analysis

6.1.2 France Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Cancer Type, 2021- 2031F

6.1.3 France Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Lung Adenocarcinoma (LUAD), 2021- 2031F

6.1.4 France Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Lung Squamous Cell carcinoma (LUSC), 2021- 2031F

6.1.5 France Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Large Cell Carcinoma, 2021- 2031F

6.1.6 France Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Others, 2021- 2031F

6.2 France Non-Small Cell Lung Cancer Diagnostics Market, By Product

6.2.1 Overview and Analysis

6.2.2 France Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Reagents & Kits, 2021- 2031F

6.2.3 France Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Instruments And Services & Softwares, 2021- 2031F

6.3 France Non-Small Cell Lung Cancer Diagnostics Market, By Test

6.3.1 Overview and Analysis

6.3.2 France Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Imaging Test, 2021- 2031F

6.3.3 France Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Molecular Test, 2021- 2031F

6.3.4 France Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Biopsy, 2021- 2031F

6.3.5 France Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Sputum Cytology, 2021- 2031F

6.3.6 France Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Thoracentesis, 2021- 2031F

6.3.7 France Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Immunohistochemistry, 2021- 2031F

6.4 France Non-Small Cell Lung Cancer Diagnostics Market, By End-User

6.4.1 Overview and Analysis

6.4.2 France Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Hospital, 2021- 2031F

6.4.3 France Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Clinical Laboratories, 2021- 2031F

6.4.4 France Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Academics, 2021- 2031F

6.4.5 France Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Others, 2021- 2031F

7 France Non-Small Cell Lung Cancer Diagnostics Market Import-Export Trade Statistics

7.1 France Non-Small Cell Lung Cancer Diagnostics Market Export to Major Countries

7.2 France Non-Small Cell Lung Cancer Diagnostics Market Imports from Major Countries

8 France Non-Small Cell Lung Cancer Diagnostics Market Key Performance Indicators

8.1 Adoption rate of new diagnostic technologies in non-small cell lung cancer detection

8.2 Rate of early-stage diagnosis of non-small cell lung cancer

8.3 Percentage of healthcare professionals trained in the latest diagnostic techniques

9 France Non-Small Cell Lung Cancer Diagnostics Market - Opportunity Assessment

9.1 France Non-Small Cell Lung Cancer Diagnostics Market Opportunity Assessment, By Cancer Type, 2021 & 2031F

9.2 France Non-Small Cell Lung Cancer Diagnostics Market Opportunity Assessment, By Product, 2021 & 2031F

9.3 France Non-Small Cell Lung Cancer Diagnostics Market Opportunity Assessment, By Test, 2021 & 2031F

9.4 France Non-Small Cell Lung Cancer Diagnostics Market Opportunity Assessment, By End-User, 2021 & 2031F

10 France Non-Small Cell Lung Cancer Diagnostics Market - Competitive Landscape

10.1 France Non-Small Cell Lung Cancer Diagnostics Market Revenue Share, By Companies, 2024

10.2 France Non-Small Cell Lung Cancer Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Related Reports

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All